Cargando…

The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial

Background: The present clinical trial aimed to examine whether adherence to Dietary Approaches to Stop Hypertension (DASH) diet could improve lipid profile, the Pro-oxidant-antioxidant balance (PAB) as well as liver function in obese adults with non-alcoholic fatty liver disease (NAFLD). Methods: S...

Descripción completa

Detalles Bibliográficos
Autores principales: Badali, Taghi, Arefhosseini, Sara, Rooholahzadegan, Farnaz, Tutunchi, Helda, Ebrahimi-Mameghani, Mehrangiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257571/
https://www.ncbi.nlm.nih.gov/pubmed/37309438
http://dx.doi.org/10.34172/hpp.2023.10
_version_ 1785057329374298112
author Badali, Taghi
Arefhosseini, Sara
Rooholahzadegan, Farnaz
Tutunchi, Helda
Ebrahimi-Mameghani, Mehrangiz
author_facet Badali, Taghi
Arefhosseini, Sara
Rooholahzadegan, Farnaz
Tutunchi, Helda
Ebrahimi-Mameghani, Mehrangiz
author_sort Badali, Taghi
collection PubMed
description Background: The present clinical trial aimed to examine whether adherence to Dietary Approaches to Stop Hypertension (DASH) diet could improve lipid profile, the Pro-oxidant-antioxidant balance (PAB) as well as liver function in obese adults with non-alcoholic fatty liver disease (NAFLD). Methods: Sixty two patients with NAFLD were equally allocated into either DASH or low-calorie diet (LCD) group for 8 weeks. The primary and secondary outcomes were determined before and after the trial. Results: Forty patients completed the trial. Significant within group differences were found in dietary saturated fat, selenium, vitamins A and E as well as body weight and body mass index (BMI) and waist circumference (WC) after the intervention (P<0.05). DASH diet showed greater significant change in systolic and diastolic blood pressure without significant differences between the groups after 8 weeks. Apart from serum high-density lipoprotein cholesterol (HDL-C) and triglyceride/HDL-C, greater reductions were found not only in serum lipids and atherogenic indices (P<0.05) but also in serum aspartate aminotransferase (AST), AST to platelet ratio index (APRI) and lipid accumulation product (LAP) in DASH group in comparison to control group (P=0.008, P=0.019 and P=0.003, respectively). Nevertheless, there was not any difference in PAB level between the groups. Furthermore, adherence to DASH diet was more effective in alleviating liver steatosis compared with usual LCD (P=0.012). Conclusion: Adherence to DASH diet appears to be more effective in improving obesity, atherogenic and liver steatosis biomarkers but not oxidative stress (OS) than usual LCD.
format Online
Article
Text
id pubmed-10257571
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Tabriz University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-102575712023-06-12 The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial Badali, Taghi Arefhosseini, Sara Rooholahzadegan, Farnaz Tutunchi, Helda Ebrahimi-Mameghani, Mehrangiz Health Promot Perspect Original Article Background: The present clinical trial aimed to examine whether adherence to Dietary Approaches to Stop Hypertension (DASH) diet could improve lipid profile, the Pro-oxidant-antioxidant balance (PAB) as well as liver function in obese adults with non-alcoholic fatty liver disease (NAFLD). Methods: Sixty two patients with NAFLD were equally allocated into either DASH or low-calorie diet (LCD) group for 8 weeks. The primary and secondary outcomes were determined before and after the trial. Results: Forty patients completed the trial. Significant within group differences were found in dietary saturated fat, selenium, vitamins A and E as well as body weight and body mass index (BMI) and waist circumference (WC) after the intervention (P<0.05). DASH diet showed greater significant change in systolic and diastolic blood pressure without significant differences between the groups after 8 weeks. Apart from serum high-density lipoprotein cholesterol (HDL-C) and triglyceride/HDL-C, greater reductions were found not only in serum lipids and atherogenic indices (P<0.05) but also in serum aspartate aminotransferase (AST), AST to platelet ratio index (APRI) and lipid accumulation product (LAP) in DASH group in comparison to control group (P=0.008, P=0.019 and P=0.003, respectively). Nevertheless, there was not any difference in PAB level between the groups. Furthermore, adherence to DASH diet was more effective in alleviating liver steatosis compared with usual LCD (P=0.012). Conclusion: Adherence to DASH diet appears to be more effective in improving obesity, atherogenic and liver steatosis biomarkers but not oxidative stress (OS) than usual LCD. Tabriz University of Medical Sciences 2023-04-30 /pmc/articles/PMC10257571/ /pubmed/37309438 http://dx.doi.org/10.34172/hpp.2023.10 Text en © 2023 The Author(s). https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Badali, Taghi
Arefhosseini, Sara
Rooholahzadegan, Farnaz
Tutunchi, Helda
Ebrahimi-Mameghani, Mehrangiz
The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
title The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
title_full The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
title_fullStr The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
title_full_unstemmed The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
title_short The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
title_sort effect of dash diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: a double-blind controlled randomized clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257571/
https://www.ncbi.nlm.nih.gov/pubmed/37309438
http://dx.doi.org/10.34172/hpp.2023.10
work_keys_str_mv AT badalitaghi theeffectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial
AT arefhosseinisara theeffectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial
AT rooholahzadeganfarnaz theeffectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial
AT tutunchihelda theeffectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial
AT ebrahimimameghanimehrangiz theeffectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial
AT badalitaghi effectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial
AT arefhosseinisara effectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial
AT rooholahzadeganfarnaz effectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial
AT tutunchihelda effectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial
AT ebrahimimameghanimehrangiz effectofdashdietonatherogenicindicesprooxidantantioxidantbalanceandliversteatosisinobeseadultswithnonalcoholicfattyliverdiseaseadoubleblindcontrolledrandomizedclinicaltrial